Dean Investment Associates LLC Sells 8,122 Shares of Encompass Health Co. (NYSE:EHC)

Dean Investment Associates LLC decreased its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 12.2% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 58,207 shares of the company's stock after selling 8,122 shares during the period. Encompass Health makes up about 0.8% of Dean Investment Associates LLC's portfolio, making the stock its 29th biggest position. Dean Investment Associates LLC owned about 0.06% of Encompass Health worth $5,625,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of EHC. XTX Topco Ltd boosted its position in Encompass Health by 91.9% in the third quarter. XTX Topco Ltd now owns 19,193 shares of the company's stock valued at $1,855,000 after buying an additional 9,191 shares in the last quarter. EP Wealth Advisors LLC acquired a new stake in shares of Encompass Health during the 3rd quarter valued at $308,000. State Street Corp grew its position in Encompass Health by 0.7% during the 3rd quarter. State Street Corp now owns 3,025,769 shares of the company's stock worth $292,410,000 after acquiring an additional 21,329 shares during the last quarter. Stifel Financial Corp increased its holdings in Encompass Health by 8.9% in the 3rd quarter. Stifel Financial Corp now owns 60,984 shares of the company's stock worth $5,893,000 after purchasing an additional 4,966 shares in the last quarter. Finally, Systematic Financial Management LP raised its position in Encompass Health by 8.3% in the third quarter. Systematic Financial Management LP now owns 461,289 shares of the company's stock valued at $44,579,000 after purchasing an additional 35,165 shares during the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

EHC has been the topic of several research reports. Royal Bank of Canada boosted their price target on Encompass Health from $105.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, October 30th. KeyCorp upped their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a research report on Tuesday, October 29th. UBS Group lifted their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a "buy" rating in a report on Wednesday, September 25th. Truist Financial reissued a "buy" rating and issued a $116.00 price objective (up previously from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th. Finally, Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, Encompass Health presently has an average rating of "Buy" and an average target price of $107.11.

Encompass Health Trading Down 0.4 %

Shares of Encompass Health stock traded down $0.37 on Friday, hitting $102.50. 536,415 shares of the company's stock traded hands, compared to its average volume of 578,782. The company has a market capitalization of $10.33 billion, a price-to-earnings ratio of 24.76, a price-to-earnings-growth ratio of 1.35 and a beta of 0.86. The company has a fifty day moving average of $98.85 and a two-hundred day moving average of $92.00. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. Encompass Health Co. has a one year low of $64.15 and a one year high of $104.55.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Monday, October 28th. The company reported $1.03 EPS for the quarter, topping the consensus estimate of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. During the same quarter last year, the firm posted $0.86 EPS. The company's quarterly revenue was up 11.9% on a year-over-year basis. As a group, sell-side analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.66%. Encompass Health's dividend payout ratio (DPR) is presently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.